Chronic obstructive pulmonary disease (COPD) is a manifestation of structural violence, the process through which societies ...

"But it's appalling that this is the first new treatment for those suffering from asthma and COPD attacks in 50 years, indicating how desperately underfunded lung health research is. "Every four ...

Novartis’ Ultibro Breezhaler is more effective in patients at risk of chronic obstructive pulmonary disease (COPD) flare-ups than GlaxoSmithKline’s rival drug, Seretide, according to new data.

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

A recent trial showed that nicotinamide riboside supplementation might reduce airway inflammation in patients with COPD who ...

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive ...

Here, Tan and other experts in the field describe how this new understanding of inflammation is informing treatment. And it's ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

Researchers have identified new lung function and blood test cutoffs to improve timely chronic hypercapnia management in ...

inhalers can help relieve your COPD symptoms. Ask your doctor to show you how to use your specific inhaler. Be sure to keep track of the expiration dates on your medication and get a new ...

These researchers found that the new classification thresholds affect ... Early evidence suggests promise for a novel COPD treatment using autologous P63+ lung progenitor cell.